SCHEMBL7879302

SCHEMBL7879302

N[C@@H](Cc1ccc(O)cc1)C(=O)Nc1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.52
BACE1 P56817 2/20 0.49
SLC7A5 Q01650 1/20 0.49
GAA P10253 1/20 0.49
CIT O14578 1/20 0.48
LNPEP Q9UIQ6 3/20 0.48
ERAP2 Q6P179 2/20 0.48
POLB P06746 1/20 0.48
NPC1 O15118 1/20 0.47
PKM P14618 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 2/20 0.46
S1PR1 P21453 1/20 0.46
S1PR3 Q99500 1/20 0.46
MEN1 O00255 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
YARS1 P54577 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9602121 0.90 ANPEP (0.58) ANPEPSLC7A5GAACITPOLB
SCHEMBL9590000 0.90 ANPEP (0.58) ANPEPSLC7A5GAACITPOLB
SCHEMBL7879201 0.88 DHODH (0.49) ANPEPGAAPOLBNPC1PKM
SCHEMBL7873337 0.88 KMT2A (0.61) ANPEPGAAPOLBNPC1PKM
SCHEMBL7873432 0.82 TSHR (0.51) ANPEPGAACITPOLBNPC1
SCHEMBL7868057 0.81 ANPEP (0.64) ANPEPBACE1CITPOLBNPC1
SCHEMBL3988488 0.80 POLB (0.43) ANPEPSLC7A5GAAPOLBNPC1
SCHEMBL26741146 0.79 ALDH1A1 (0.60) ANPEPGAAPOLBNPC1PKM
SCHEMBL16993871 0.79 BACE1 (0.68) BACE1SLC7A5GAACITLNPEP
SCHEMBL26741187 0.79 ALDH1A1 (0.60) ANPEPGAAPOLBNPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US disclosed